Skip to content
Tirzepatide Price

Medicare GLP-1 Bridge: who qualifies and what Zepbound costs

By the Tirzepatide Price data desk · Article updated 20 Nov 2026 · Prices checked 21 Nov 2026

What it covers

Medicare lists three drugs under the Bridge:

  • Zepbound, as the KwikPen only. Single-dose Zepbound vials and pens are not covered.
  • Wegovy, as the injection or the tablet.
  • Foundayo, as the tablet.

Mounjaro is not on the list. The programme is available nationwide, including US territories (Medicare.gov).

Who qualifies

You need Medicare drug coverage of one of these kinds:

  • A standalone Medicare drug plan (PDP).
  • A Medicare Advantage coordinated care plan with drug coverage.
  • A Special Needs Plan.
  • An employer or union group waiver plan.
  • The Limited Income Newly Eligible Transition (LI NET) programme.

You must be 18 or older and meet one of these when you start GLP-1 therapy:

  • A body mass index (BMI) of 35 or higher.
  • A BMI of 30 or higher with diastolic heart failure, uncontrolled high blood pressure, or chronic kidney disease at stage 3a or higher.
  • A BMI of 27 or higher with prediabetes, a previous heart attack or stroke, or peripheral artery disease with symptoms.

These are Medicare's criteria, quoted from Medicare.gov. Medicare has an eligibility questionnaire on the same page.

Who does not qualify

  • People who already get a GLP-1 drug covered through their Part D plan.
  • People with type 2 diabetes, moderate to severe sleep apnea or fatty liver disease. Medicare says their Part D plan might cover a GLP-1 for those conditions instead.
  • People with Medicare but no Part D drug coverage.

What it costs

The copay is $50 for a one-month supply, which Medicare defines as 28 or 30 days depending on the drug. A Zepbound KwikPen holds four weekly doses, so a year takes 13 fills, or $650. The same KwikPen bought with cash at LillyDirect is $299 at 2.5 mg and $449 at 15 mg per fill.

Because a separate Medicare programme pays for the drug, the copay behaves differently from a normal Part D copay. Medicare says it:

  • does not count towards your Part D deductible or out-of-pocket limit;
  • cannot be lowered by Extra Help;
  • cannot be spread over several months with the Medicare Prescription Payment Plan.

Lilly's savings card cannot be combined with Medicare (card terms).

How the prescription works

Your doctor or other provider sends a prescription for a covered drug to the pharmacy and completes a prior authorization when asked. The provider must certify that the drug is used as part of a lifestyle programme that focuses on diet and exercise. Medicare then sends a letter confirming coverage. The authorization stays valid, including for refills and dose changes, until 31 December 2027 unless you change to a different GLP-1 (Medicare.gov).

Lilly offers the Bridge price for the Zepbound KwikPen through LillyDirect. We list the Bridge beside cash prices on the Zepbound price page.

This page reports prices and rules. It is not medical advice, and we do not recommend any drug, dose, pharmacy or prescriber. Tirzepatide is a prescription medicine. Talk to a licensed clinician before starting, changing or stopping treatment, and read the FDA-approved label, including the boxed warning.

What we do not know

Medicare calls the Bridge temporary and gives 31 December 2027 as its end. We have not found a statement of what replaces it. CMS describes a separate BALANCE model under which it negotiates GLP-1 terms with manufacturers for state Medicaid agencies and Part D sponsors. We have not verified which plans or states take part. The launch is described in the CMS press release.

Common questions

Does the Bridge cover Zepbound vials?

No. Medicare covers the Zepbound KwikPen only and says the programme does not cover single-dose vials or pens.

Does it cover Mounjaro?

Mounjaro is not on the Bridge list. Its label covers type 2 diabetes, and Medicare says people with type 2 diabetes are not eligible for the Bridge because their Part D plan might cover a GLP-1.

Does the copay end on 1 January 2027?

No. The Bridge runs to 31 December 2027. Other offers do end on 31 December 2026. See what changes in January 2027.

Sources

Checked 20 Nov 2026.

  1. Medicare.gov: weight loss drugs and the Medicare GLP-1 Bridge
  2. CMS press release: CMS launches Medicare GLP-1 Bridge
  3. LillyDirect: Medicare GLP-1 Bridge
  4. Zepbound savings card terms, Eli Lilly
  5. CMS BALANCE model
  6. Mounjaro prescribing information (FDA-approved label), Eli Lilly, revised November 2026